First Foundation Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,352
Closed -$1.74M 334
2024
Q4
$1.74M Buy
11,352
+2,800
+33% +$472K 0.07% 134
2024
Q3
$1.66M Buy
+8,552
New +$1.79M 0.06% 141
2017
Q1
Sell
-4,031
Closed -$1.14M 319
2016
Q4
$1.14M Sell
4,031
-9,109
-69% -$2.7M 0.07% 130
2016
Q3
$4.11M Sell
13,140
-5,985
-31% -$1.77M 0.28% 68
2016
Q2
$4.63M Sell
19,125
-1,806
-9% -$476K 0.33% 58
2016
Q1
$5.45M Buy
20,931
+5,847
+39% +$1.54M 0.4% 56
2015
Q4
$4.62M Buy
15,084
+376
+3% +$108K 0.32% 66
2015
Q3
$4.29M Buy
+14,708
New +$4.86M 0.35% 61

Other funds holding BIIB

First Foundation Advisors's BIIB Position: Q1 2025 in Review

First Foundation Advisors sold out of Biogen (BIIB) in Q1 2025, closing a stake of 11,352 shares — an estimated $1.74M sold.

First Foundation Advisors first reported a position in BIIB in Q3 2015 and held it in 8 quarters. The position peaked at $5.45M in Q1 2016. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • First Foundation Advisors reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • First Foundation Advisors sold 11,352 Biogen shares in Q1 2025, an estimated $1.74M.
  • First Foundation Advisors first reported a position in Biogen in Q3 2015 and held it in 8 quarters.
  • First Foundation Advisors's Biogen position peaked at $5.45M in Q1 2016.
  • 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on First Foundation Advisors's 13F filing for Q1 2025, filed 8 May 2025.